Intensive care is the most data-rich environment in any hospital, and with high volumes of high-fidelity clinical data it is an impeccable location to apply AI. With AlgoDx’s technology, we enable early detection of patient deterioration by augmenting healthcare provider clinical decision-making.
In a data-rich environment such as the intensive care unit, some signs of patient deterioration can be difficult to spot in time. Our product portfolio includes machine learning algorithms intended to assist clinical decision making in intensive care. Developed for conditions with high unmet medical need, these algorithms are designed to generate robust clinical evidence for product claims, covering clinical and health-economic benefits as well as potential risks.
AlgoDx intensive care proprietary pipeline as of March 2023
in intensive care
Post-marketing clinical follow-up
|NAVOY® for sepsis prediction
|Algorithm for prediction of Acute Kidney Injury
|Undisclosed Therapeutic Indications|
Clinical trials – AlgoDx sponsored clinical research
For more information on our ongoing clinical projects in intensive care, visit clinicaltrials.gov
Early Prediction of Sepsis in Hospitalized Patients Using a Machine Learning Algorithm, a Randomized Clinical Validation Trial.
Protocol number: NCT04570618
Integration and Evaluation of a Machine Learning Algorithm for Sepsis Prediction in an Electronic Health Record System – a Prospective Observational Study.
Protocol number: NCT05095220
Clinical validation of an algorithm for prediction of Acute Kidney Injury in ICU patients.
Protocol number: NCT05424874
AlgoDx products in the clinical workflow – case study: NAVOY®